126 related articles for article (PubMed ID: 37081668)
1. Decrease in CD226 expression on CD4
Li C; Zhou J; Shao J; Yuan L; Cheng Q; Wang L; Duan Z
Biosci Trends; 2023 May; 17(2):168-171. PubMed ID: 37081668
[TBL] [Abstract][Full Text] [Related]
2. Alteration of CD226/TIGIT immune checkpoint on T cells in the pathogenesis of primary Sjögren's syndrome.
Deng C; Chen Y; Li W; Peng L; Luo X; Peng Y; Zhao L; Wu Q; Zhang W; Zhang X; Fei Y
J Autoimmun; 2020 Sep; 113():102485. PubMed ID: 32466852
[TBL] [Abstract][Full Text] [Related]
3. Expansion of circulating peripheral TIGIT+CD226+ CD4 T cells with enhanced effector functions in dermatomyositis.
Li W; Deng C; Yang H; Lu X; Li S; Liu X; Chen F; Chen L; Shu X; Zhang L; Liu Q; Wang G; Peng Q
Arthritis Res Ther; 2021 Jan; 23(1):15. PubMed ID: 33413573
[TBL] [Abstract][Full Text] [Related]
4. Imbalance of the CD226/TIGIT Immune Checkpoint Is Involved in the Pathogenesis of Primary Biliary Cholangitis.
Deng C; Li W; Fei Y; Wang L; Chen Y; Zeng X; Zhang F; Li Y
Front Immunol; 2020; 11():1619. PubMed ID: 32793241
[TBL] [Abstract][Full Text] [Related]
5. CD8
Wang M; Bu J; Zhou M; Sido J; Lin Y; Liu G; Lin Q; Xu X; Leavenworth JW; Shen E
Clin Immunol; 2018 May; 190():64-73. PubMed ID: 28893624
[TBL] [Abstract][Full Text] [Related]
6. The TIGIT/CD226 axis regulates human T cell function.
Lozano E; Dominguez-Villar M; Kuchroo V; Hafler DA
J Immunol; 2012 Apr; 188(8):3869-75. PubMed ID: 22427644
[TBL] [Abstract][Full Text] [Related]
7. CD226 opposes TIGIT to disrupt Tregs in melanoma.
Fourcade J; Sun Z; Chauvin JM; Ka M; Davar D; Pagliano O; Wang H; Saada S; Menna C; Amin R; Sander C; Kirkwood JM; Korman AJ; Zarour HM
JCI Insight; 2018 Jul; 3(14):. PubMed ID: 30046006
[TBL] [Abstract][Full Text] [Related]
8. Human CD4
Šunina M; Alnek K; Kisand K; Uibo R
Scand J Immunol; 2021 Sep; 94(3):e13089. PubMed ID: 35971920
[TBL] [Abstract][Full Text] [Related]
9. Expression of the immune checkpoint molecules CD226 and TIGIT in preeclampsia patients.
Li C; Liu H; Duan Z
BMC Immunol; 2024 Feb; 25(1):12. PubMed ID: 38326745
[TBL] [Abstract][Full Text] [Related]
10. TIGIT and CD155 as Immune-Modulator Receptor and Ligand on CD4
Kamrani A; Soltani-Zangbar MS; Shiri S; Yousefzadeh Y; Pourakbari R; Aghebati-Maleki L; Mehdizadeh A; Danaii S; Jadidi-Niaragh F; Yousefi B; Kafil HS; Hojjat-Farsangi M; Motavalli R; Zolfaghari M; Haji-Fatahaliha M; Mahmoodpoor A; Ahmadian Heris J; Emdadi A; Yousefi M
Immunol Invest; 2022 May; 51(4):1023-1038. PubMed ID: 33855917
[TBL] [Abstract][Full Text] [Related]
11. Competitive binding of CD226/TIGIT with poliovirus receptor regulates macrophage polarization and is involved in vascularized skin graft rejection.
Zhang D; Liu Y; Ma J; Xu Z; Duan C; Wang Y; Li X; Han J; Zhuang R
Am J Transplant; 2023 Jul; 23(7):920-934. PubMed ID: 37054890
[TBL] [Abstract][Full Text] [Related]
12. Recovery of CD226-TIGIT
Long Y; Wang C; Xia C; Li X; Fan C; Zhao X; Liu C
Immunol Lett; 2020 Feb; 218():30-39. PubMed ID: 31883787
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the Characteristics of TIGIT-Expressing CD3
Zhang X; Lu X; Cheung AKL; Zhang Q; Liu Z; Li Z; Yuan L; Wang R; Liu Y; Tang B; Xia H; Wu H; Zhang T; Su B
Front Immunol; 2021; 12():602492. PubMed ID: 33717085
[TBL] [Abstract][Full Text] [Related]
14. CD226 and TIGIT Cooperate in the Differentiation and Maturation of Human Tfh Cells.
Yasutomi M; Christiaansen AF; Imai N; Martin-Orozco N; Forst CV; Chen G; Ueno H
Front Immunol; 2022; 13():840457. PubMed ID: 35273617
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of TIGIT but not neuropilin-1 in patients with type 2 diabetes mellitus.
Hoseini-Aghdam M; Sheikh V; Eftekharian MM; Rezaeepoor M; Behzad M
Immunol Lett; 2020 Sep; 225():1-8. PubMed ID: 32540486
[TBL] [Abstract][Full Text] [Related]
16. The CD226/TIGIT axis is involved in T cell hypo-responsiveness appearance in long-term kidney transplant recipients.
Del Bello A; Gouin A; Chaubet C; Kamar N; Treiner E
Sci Rep; 2022 Jul; 12(1):11821. PubMed ID: 35821240
[TBL] [Abstract][Full Text] [Related]
17. Expression of the Inhibitory Receptor TIGIT Is Up-Regulated Specifically on NK Cells With CD226 Activating Receptor From HIV-Infected Individuals.
Yin X; Liu T; Wang Z; Ma M; Lei J; Zhang Z; Fu S; Fu Y; Hu Q; Ding H; Han X; Xu J; Shang H; Jiang Y
Front Immunol; 2018; 9():2341. PubMed ID: 30364127
[TBL] [Abstract][Full Text] [Related]
18. Examination of the TIGIT-CD226-CD112-CD155 Immune Checkpoint Network during a Healthy Pregnancy.
Meggyes M; Nagy DU; Feik T; Boros A; Polgar B; Szereday L
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142692
[No Abstract] [Full Text] [Related]
19. The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergy.
Arruga F; Rubin M; Papazoglou D; Iannello A; Ioannou N; Moia R; Rossi D; Gaidano G; Coscia M; Laurenti L; D'Arena G; Allan JN; Furman RR; Vaisitti T; Ramsay AG; Deaglio S
Haematologica; 2023 Aug; 108(8):2101-2115. PubMed ID: 36655432
[TBL] [Abstract][Full Text] [Related]
20. CD226 attenuates Treg suppressive capacity via CTLA-4 and TIGIT during EAE.
Wang N; Liang S; Jin J; Fang L; Ma Q; Wang X; Song Y; Chen L
Immunol Res; 2019 Dec; 67(6):486-496. PubMed ID: 31919790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
